Companies / Monopar Therapeutics Inc. / Activity
Activity — Monopar Therapeutics Inc.
9 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Dec 31, 2025 | Robinson Chandler CEO | Other | Common Stock | $167.0K | -3K -2.90% | 85,718 1.28% of shares | low |
| Dec 31, 2025 | Cittadine Andrew Executive | Other | Common Stock | $123.4K | -2K -3.59% | 50,726 0.76% of shares | low |
| Jan 28, 2025 | Robinson Chandler CEO | Other | Common Stock | $0 | +63K | 62,815 0.94% of shares | low |
| Mar 2, 2026 | Rodriguez Susan Executive | Grant | Stock Options | — | +49K | 48,728 0.73% of shares | low |
| Dec 31, 2025 | Robinson Chandler CEO | Exercise | Restricted Stock Unit | — | -9K -7.17% | 113,008 1.68% of shares | low |
| Dec 31, 2025 | Robinson Chandler CEO | Exercise | Common Stock | — | +9K +10.97% | 88,276 1.32% of shares | low |
| Dec 31, 2025 | Cittadine Andrew Executive | Exercise | Restricted Stock Unit | — | -4K -8.23% | 48,267 0.72% of shares | low |
| Dec 31, 2025 | Cittadine Andrew Executive | Exercise | Common Stock | — | +4K +8.96% | 52,615 0.78% of shares | low |
| Jan 1, 2026 | Rioux Patrice | Grant | Stock Option | — | +2K | 2,000 0.03% of shares | low |